Annual SG&A:
$49.01M+$24.43M(+99.38%)Summary
- As of today, APGE annual SG&A is $49.01 million, with the most recent change of +$24.43 million (+99.38%) on December 31, 2024.
- During the last 3 years, APGE annual SG&A has risen by +$46.06 million (+1566.27%).
- APGE annual SG&A is now at all-time high.
Performance
APGE SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$17.10M-$362.00K(-2.07%)Summary
- As of today, APGE quarterly SG&A is $17.10 million, with the most recent change of -$362.00 thousand (-2.07%) on September 30, 2025.
- Over the past year, APGE quarterly SG&A has increased by +$4.13 million (+31.82%).
- APGE quarterly SG&A is now -2.07% below its all-time high of $17.46 million, reached on June 30, 2025.
Performance
APGE Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$1.59B-$253.67M(-19.03%)Summary
- As of today, APGE TTM SG&A is -$1.59 billion, with the most recent change of -$253.67 million (-19.03%) on September 30, 2025.
- Over the past year, APGE TTM SG&A has dropped by -$1.63 billion (-3918.87%).
- APGE TTM SG&A is now -3888.67% below its all-time high of -$39.78 million.
Performance
APGE TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
APGE Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +99.4% | +31.8% | -3918.9% |
| 3Y3 Years | +1566.3% | +2649.2% | -10000.0% |
| 5Y5 Years | +1566.3% | +10000.0% | -10000.0% |
APGE Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +1566.3% | -2.1% | +2649.2% | -3888.7% | at low |
| 5Y | 5-Year | at high | +1566.3% | -2.1% | >+9999.0% | -3888.7% | at low |
| All-Time | All-Time | at high | +1566.3% | -2.1% | >+9999.0% | -3888.7% | at low |
APGE Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $17.10M(-2.1%) | $66.92M(+6.6%) |
| Jun 2025 | - | $17.46M(+4.5%) | $62.80M(+11.6%) |
| Mar 2025 | - | $16.71M(+6.8%) | $56.25M(+14.8%) |
| Dec 2024 | $49.01M(+99.4%) | $15.65M(+20.7%) | $49.01M(+17.9%) |
| Sep 2024 | - | $12.97M(+18.8%) | $41.55M(+16.0%) |
| Jun 2024 | - | $10.92M(+15.3%) | $35.82M(+20.0%) |
| Mar 2024 | - | $9.46M(+15.4%) | $29.84M(+21.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $24.58M(+735.7%) | $8.20M(+13.3%) | $24.58M(+50.1%) |
| Sep 2023 | - | $7.24M(+46.5%) | $16.38M(+67.7%) |
| Jun 2023 | - | $4.94M(+17.5%) | $9.76M(+88.0%) |
| Mar 2023 | - | $4.20M(+575.7%) | $5.19M(+394.6%) |
| Dec 2022 | $2.94M | - | - |
| Sep 2022 | - | $622.00K(+69.0%) | $1.05M(+145.3%) |
| Jun 2022 | - | $368.00K(+513.3%) | $428.00K(+613.3%) |
| Mar 2022 | - | $60.00K | $60.00K |
FAQ
- What is Apogee Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. annual SG&A year-on-year change?
- What is Apogee Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Apogee Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. TTM SG&A year-on-year change?
What is Apogee Therapeutics, Inc. annual SG&A?
The current annual SG&A of APGE is $49.01M
What is the all-time high annual SG&A for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high annual SG&A is $49.01M
What is Apogee Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, APGE annual SG&A has changed by +$24.43M (+99.38%)
What is Apogee Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of APGE is $17.10M
What is the all-time high quarterly SG&A for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high quarterly SG&A is $17.46M
What is Apogee Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, APGE quarterly SG&A has changed by +$4.13M (+31.82%)
What is Apogee Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of APGE is -$1.59B
What is the all-time high TTM SG&A for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high TTM SG&A is -$39.78M
What is Apogee Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, APGE TTM SG&A has changed by -$1.63B (-3918.87%)